Efficacy of EC-MPS compared to MMF in Chinese patients as measured by the incidence of biopsy proven acute rejection, graft loss, or death within six months of treatment in de novo renal transplant recipients. [clinicaltrials_resource:7f4df3bc828ff46ed66cb1abedabc892]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Efficacy of EC-MPS compared to MMF in Chinese patients as measured by the incidence of biopsy proven acute rejection, graft loss, or death within six months of treatment in de novo renal transplant recipients. [clinicaltrials_resource:7f4df3bc828ff46ed66cb1abedabc892]
Bio2RDF identifier
7f4df3bc828ff46ed66cb1abedabc892
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7f4df3bc828ff46ed66cb1abedabc892
measure [clinicaltrials_vocabulary:measure]
Efficacy of EC-MPS compared to ...... o renal transplant recipients.
identifier
clinicaltrials_resource:7f4df3bc828ff46ed66cb1abedabc892
title
Efficacy of EC-MPS compared to ...... o renal transplant recipients.
@en
type
label
Efficacy of EC-MPS compared to ...... df3bc828ff46ed66cb1abedabc892]
@en